[{"Assets_0_Q3_USD":1892218000.0,"CommonStockSharesConverted_0_Q3_shares":55320000.0,"CommonStockSharesOutstanding_0_Q3_shares":55320000.0,"EarningsPerShareBasic_1_Q3_USD":-3.73,"EarningsPerShareBasic_3_Q3_USD":-10.27,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-405408000.0,"NetIncomeLossConverted_1_Q3_USD":-206033000.0,"NetIncomeLossConverted_3_Q3_USD":-566261000.0,"StockholdersEquity_0_Q3_USD":1471710000.0,"RevenuesConverted_1_Q3_USD":8910000.0,"RevenuesConverted_3_Q3_USD":34677000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191031"}]